{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T15:40:26Z","timestamp":1784302826050,"version":"3.55.0"},"reference-count":75,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2025,8,5]],"date-time":"2025-08-05T00:00:00Z","timestamp":1754352000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,8,5]],"date-time":"2025-08-05T00:00:00Z","timestamp":1754352000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Rheumatol Int"],"DOI":"10.1007\/s00296-025-05932-1","type":"journal-article","created":{"date-parts":[[2025,8,5]],"date-time":"2025-08-05T10:55:20Z","timestamp":1754391320000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Classic lipid profile and lipoprotein(a) in systemic sclerosis: a systematic review and meta-analysis of case-control studies"],"prefix":"10.1007","volume":"45","author":[{"ORCID":"https:\/\/orcid.org\/0009-0008-8925-829X","authenticated-orcid":false,"given":"Christina","family":"Mastori-Kourmpani","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9246-8249","authenticated-orcid":false,"given":"Anastasios","family":"Makris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7162-3323","authenticated-orcid":false,"given":"Evangelos","family":"Liberopoulos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5484-2930","authenticated-orcid":false,"given":"Petros P.","family":"Sfikakis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9749-5075","authenticated-orcid":false,"given":"Aris P.","family":"Agouridis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,8,5]]},"reference":[{"key":"5932_CR1","doi-asserted-by":"publisher","DOI":"10.1136\/rmdopen-2021-001694","author":"VK Bournia","year":"2021","unstructured":"Bournia VK, Fragoulis GE, Mitrou P, Mathioudakis K, Tsolakidis A, Konstantonis G, Vourli G, Paraskevis D, Tektonidou MG, Sfikakis PP (2021) All-cause mortality in systemic rheumatic diseases under treatment compared with the general population, 2015\u20132019. RMD Open 7. https:\/\/doi.org\/10.1136\/rmdopen-2021-001694","journal-title":"RMD Open 7"},{"key":"5932_CR2","doi-asserted-by":"publisher","first-page":"2837","DOI":"10.1007\/s00296-024-05733-y","volume":"44","author":"VK Bournia","year":"2024","unstructured":"Bournia VK, Fragoulis GE, Mitrou P, Tsolakidis A, Mathioudakis K, Vassilopoulos D, Tektonidou M, Paraskevis D, Sfikakis PP (2024) Increased prevalence of inflammatory arthritis, systemic lupus erythematosus and systemic sclerosis, during 2020\u20132023 versus 2016\u20132019 in a nation-wide cohort study. Rheumatol Int 44:2837\u20132846. https:\/\/doi.org\/10.1007\/s00296-024-05733-y","journal-title":"Rheumatol Int"},{"key":"5932_CR3","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1016\/s0140-6736(22)01692-0","volume":"401","author":"ER Volkmann","year":"2023","unstructured":"Volkmann ER, Andr\u00e9asson K, Smith V (2023) Systemic sclerosis. Lancet 401:304\u2013318. https:\/\/doi.org\/10.1016\/s0140-6736(22)01692-0","journal-title":"Lancet"},{"key":"5932_CR4","doi-asserted-by":"publisher","first-page":"1060","DOI":"10.3899\/jrheum.2023-1113","volume":"51","author":"A Makris","year":"2024","unstructured":"Makris A, Panagiotopoulos A, Distler O, Sfikakis PP (2024) Systemic sclerosis sine scleroderma: a time of reappraisal. J Rheumatol 51:1060\u20131068. https:\/\/doi.org\/10.3899\/jrheum.2023-1113","journal-title":"J Rheumatol"},{"key":"5932_CR5","doi-asserted-by":"publisher","first-page":"e23009","DOI":"10.1097\/md.0000000000023009","volume":"99","author":"X Cen","year":"2020","unstructured":"Cen X, Feng S, Wei S, Yan L, Sun L (2020) Systemic sclerosis and risk of cardiovascular disease: A PRISMA-compliant systemic review and meta-analysis of cohort studies. Med (Baltim) 99:e23009. https:\/\/doi.org\/10.1097\/md.0000000000023009","journal-title":"Med (Baltim)"},{"key":"5932_CR6","doi-asserted-by":"publisher","first-page":"16039","DOI":"10.1038\/nrdp.2016.39","volume":"2","author":"A Kaul","year":"2016","unstructured":"Kaul A, Gordon C, Crow MK, Touma Z, Urowitz MB, van Vollenhoven R, Ruiz-Irastorza G, Hughes G (2016) Systemic lupus erythematosus. Nat Rev Dis Primers 2:16039. https:\/\/doi.org\/10.1038\/nrdp.2016.39","journal-title":"Nat Rev Dis Primers"},{"key":"5932_CR7","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1177\/0961203307081113","volume":"16","author":"MB Urowitz","year":"2007","unstructured":"Urowitz MB, Gladman D, Iba\u00f1ez D, Fortin P, Sanchez-Guerrero J, Bae S, Clarke A, Bernatsky S, Gordon C, Hanly J, Wallace D, Isenberg D, Ginzler E, Merrill J, Alarcon G, Steinsson K, Petri M, Dooley MA, Bruce I, Manzi S, Khamashta M, Ramsey-Goldman R, Zoma A, Sturfelt G, Nived O, Maddison P, Font J, van Vollenhoven R, Aranow C, Kalunian K, Stoll T, Buyon J (2007) Clinical manifestations and coronary artery disease risk factors at diagnosis of systemic lupus erythematosus: data from an international inception cohort. Lupus 16:731\u2013735. https:\/\/doi.org\/10.1177\/0961203307081113","journal-title":"Lupus"},{"key":"5932_CR8","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1111\/joim.12357","volume":"278","author":"M Wigren","year":"2015","unstructured":"Wigren M, Nilsson J, Kaplan MJ (2015) Pathogenic immunity in systemic lupus erythematosus and atherosclerosis: common mechanisms and possible targets for intervention. J Intern Med 278:494\u2013506. https:\/\/doi.org\/10.1111\/joim.12357","journal-title":"J Intern Med"},{"key":"5932_CR9","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1177\/096120339700600610","volume":"6","author":"EF Borba","year":"1997","unstructured":"Borba EF, Bonf\u00e1 E (1997) Dyslipoproteinemias in systemic lupus erythematosus: influence of disease, activity, and anticardiolipin antibodies. Lupus 6:533\u2013539. https:\/\/doi.org\/10.1177\/096120339700600610","journal-title":"Lupus"},{"key":"5932_CR10","doi-asserted-by":"publisher","first-page":"223","DOI":"10.2147\/oarrr.S264466","volume":"12","author":"G Dessie","year":"2020","unstructured":"Dessie G, Tadesse Y, Demelash B, Genet S (2020) Assessment of serum lipid profiles and High-sensitivity C-reactive protein among patients suffering from rheumatoid arthritis at Tikur Anbessa specialized hospital, addis ababa, ethiopia: A Cross-Sectional study. Open Access Rheumatol 12:223\u2013232. https:\/\/doi.org\/10.2147\/oarrr.S264466","journal-title":"Open Access Rheumatol"},{"key":"5932_CR11","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1136\/ard.2008.101964","volume":"68","author":"E Choy","year":"2009","unstructured":"Choy E, Sattar N (2009) Interpreting lipid levels in the context of high-grade inflammatory States with a focus on rheumatoid arthritis: a challenge to conventional cardiovascular risk actions. Ann Rheum Dis 68:460\u2013469. https:\/\/doi.org\/10.1136\/ard.2008.101964","journal-title":"Ann Rheum Dis"},{"key":"5932_CR12","doi-asserted-by":"publisher","DOI":"10.1002\/art.43097","author":"N Papazoglou","year":"2024","unstructured":"Papazoglou N, Sfikakis PP, Tektonidou MG (2024) Atherosclerotic plaque progression and incident cardiovascular events in a 10-year prospective study of patients with systemic lupus erythematosus: the impact of persistent cardiovascular risk factor target attainment and sustained DORIS remission. Arthritis Rheumatol. https:\/\/doi.org\/10.1002\/art.43097","journal-title":"Arthritis Rheumatol"},{"key":"5932_CR13","doi-asserted-by":"publisher","DOI":"10.1136\/rmdopen-2023-003601","author":"GC Drosos","year":"2023","unstructured":"Drosos GC, Konstantonis G, Sfikakis PP, Tektonidou MG (2023) Cardiovascular risk assessment in patients with antiphospholipid syndrome: a cross-sectional performance analysis of nine clinical risk prediction tools. RMD Open. https:\/\/doi.org\/10.1136\/rmdopen-2023-003601","journal-title":"RMD Open"},{"key":"5932_CR14","doi-asserted-by":"publisher","DOI":"10.1136\/rmdopen-2024-004991","author":"GA Karpouzas","year":"2024","unstructured":"Karpouzas GA, Papotti B, Ormseth SR, Palumbo M, Hernandez E, Adorni MP, Zimetti F, Ronda N (2024) Changes in serum cholesterol loading capacity are linked to coronary atherosclerosis progression in rheumatoid arthritis. RMD Open. https:\/\/doi.org\/10.1136\/rmdopen-2024-004991","journal-title":"RMD Open"},{"key":"5932_CR15","doi-asserted-by":"publisher","first-page":"2078","DOI":"10.1002\/art.30380","volume":"63","author":"K Au","year":"2011","unstructured":"Au K, Singh MK, Bodukam V, Bae S, Maranian P, Ogawa R, Spiegel B, McMahon M, Hahn B, Khanna D (2011) Atherosclerosis in systemic sclerosis: a systematic review and meta-analysis. Arthritis Rheum 63:2078\u20132090. https:\/\/doi.org\/10.1002\/art.30380","journal-title":"Arthritis Rheum"},{"key":"5932_CR16","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1016\/j.clinbiochem.2006.11.018","volume":"40","author":"M Be\u0107arevi\u0107","year":"2007","unstructured":"Be\u0107arevi\u0107 M, Singh S, Majki\u0107-Singh N (2007) Lipoprotein (a) and Apolipoprotein (a) in primary antiphospholipid syndrome. Clin Biochem 40:317\u2013320. https:\/\/doi.org\/10.1016\/j.clinbiochem.2006.11.018","journal-title":"Clin Biochem"},{"key":"5932_CR17","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.cca.2007.12.015","volume":"390","author":"J Wang","year":"2008","unstructured":"Wang J, Hu B, Kong L, Cai H, Zhang C (2008) Native, oxidized lipoprotein(a) and lipoprotein(a) immune complex in patients with active and inactive rheumatoid arthritis: plasma concentrations and relationship to inflammation. Clin Chim Acta 390:67\u201371. https:\/\/doi.org\/10.1016\/j.cca.2007.12.015","journal-title":"Clin Chim Acta"},{"key":"5932_CR18","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.1093\/rheumatology\/36.10.1045","volume":"36","author":"PR Ames","year":"1997","unstructured":"Ames PR, Lupoli S, Alves J, Atsumi T, Edwards C, Iannaccone L, Khamashta MA, Hughes GR, Brancaccio V (1997) The coagulation\/fibrinolysis balance in systemic sclerosis: evidence for a haematological stress syndrome. Br J Rheumatol 36:1045\u20131050. https:\/\/doi.org\/10.1093\/rheumatology\/36.10.1045","journal-title":"Br J Rheumatol"},{"key":"5932_CR19","doi-asserted-by":"publisher","first-page":"480784","DOI":"10.1155\/2012\/480784","volume":"2012","author":"I Missala","year":"2012","unstructured":"Missala I, Kassner U, Steinhagen-Thiessen E (2012) A systematic literature review of the association of lipoprotein(a) and autoimmune diseases and atherosclerosis. Int J Rheumatol 2012:480784. https:\/\/doi.org\/10.1155\/2012\/480784","journal-title":"Int J Rheumatol"},{"key":"5932_CR20","doi-asserted-by":"publisher","first-page":"761721","DOI":"10.3389\/fmolb.2021.761721","volume":"8","author":"Z Gogulska","year":"2021","unstructured":"Gogulska Z, Smolenska Z, Turyn J, Mika A, Zdrojewski Z (2021) Lipid alterations in systemic sclerosis. Front Mol Biosci 8:761721. https:\/\/doi.org\/10.3389\/fmolb.2021.761721","journal-title":"Front Mol Biosci"},{"key":"5932_CR21","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1080\/10408363.2017.1415866","volume":"55","author":"CA Scipione","year":"2018","unstructured":"Scipione CA, Koschinsky ML, Boffa MB (2018) Lipoprotein(a) in clinical practice: new perspectives from basic and translational science. Crit Rev Clin Lab Sci 55:33\u201354. https:\/\/doi.org\/10.1080\/10408363.2017.1415866","journal-title":"Crit Rev Clin Lab Sci"},{"key":"5932_CR22","doi-asserted-by":"publisher","first-page":"n71","DOI":"10.1136\/bmj.n71","volume":"372","author":"MJ Page","year":"2021","unstructured":"Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, Shamseer L, Tetzlaff JM, Akl EA, Brennan SE, Chou R, Glanville J, Grimshaw JM, Hr\u00f3bjartsson A, Lalu MM, Li T, Loder EW, Mayo-Wilson E, McDonald S, McGuinness LA, Stewart LA, Thomas J, Tricco AC, Welch VA, Whiting P, Moher D (2021) The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ 372:n71. https:\/\/doi.org\/10.1136\/bmj.n71","journal-title":"BMJ"},{"key":"5932_CR23","doi-asserted-by":"publisher","first-page":"2520","DOI":"10.1177\/0962280219889080","volume":"29","author":"S McGrath","year":"2020","unstructured":"McGrath S, Zhao X, Steele R, Thombs BD, Benedetti A (2020) Estimating the sample mean and standard deviation from commonly reported quantiles in meta-analysis. Stat Methods Med Res 29:2520\u20132537. https:\/\/doi.org\/10.1177\/0962280219889080","journal-title":"Stat Methods Med Res"},{"key":"5932_CR24","doi-asserted-by":"publisher","first-page":"1060","DOI":"10.1002\/art.1780380807","volume":"38","author":"KR Bruckdorfer","year":"1995","unstructured":"Bruckdorfer KR, Hillary JB, Bunce T, Vancheeswaran R, Black CM (1995) Increased susceptibility to oxidation of low-density lipoproteins isolated from patients with systemic sclerosis. Arthritis Rheum 38:1060\u20131067. https:\/\/doi.org\/10.1002\/art.1780380807","journal-title":"Arthritis Rheum"},{"key":"5932_CR25","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1136\/ard.59.1.39","volume":"59","author":"M Ho","year":"2000","unstructured":"Ho M, Veale D, Eastmond C, Nuki G, Belch J (2000) Macrovascular disease and systemic sclerosis. Ann Rheum Dis 59:39\u201343. https:\/\/doi.org\/10.1136\/ard.59.1.39","journal-title":"Ann Rheum Dis"},{"key":"5932_CR26","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1053\/sarh.2002.50011","volume":"32","author":"MM Cerinic","year":"2003","unstructured":"Cerinic MM, Valentini G, Sorano GG, D\u2019Angelo S, Cuomo G, Fenu L, Generini S, Cinotti S, Morfini M, Pignone A, Guiducci S, Del Rosso A, Kalfin R, Das D, Marongiu F (2003) Blood coagulation, fibrinolysis, and markers of endothelial dysfunction in systemic sclerosis. Semin Arthritis Rheum 32:285\u2013295. https:\/\/doi.org\/10.1053\/sarh.2002.50011","journal-title":"Semin Arthritis Rheum"},{"key":"5932_CR27","first-page":"199","volume":"21","author":"NA Zakopoulos","year":"2003","unstructured":"Zakopoulos NA, Kotsis VT, Gialafos EJ, Papamichael CM, Pitiriga V, Mitsibounas DN, Mavrikakis ME (2003) Systemic sclerosis is not associated with clinical or ambulatory blood pressure. Clin Exp Rheumatol 21:199\u2013204","journal-title":"Clin Exp Rheumatol"},{"key":"5932_CR28","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1007\/s00296-004-0580-8","volume":"25","author":"EF Borba","year":"2005","unstructured":"Borba EF, Borges CT, Bonf\u00e1 E (2005) Lipoprotein profile in limited systemic sclerosis. Rheumatol Int 25:379\u2013383. https:\/\/doi.org\/10.1007\/s00296-004-0580-8","journal-title":"Rheumatol Int"},{"key":"5932_CR29","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1016\/j.cca.2005.07.015","volume":"364","author":"G Lippi","year":"2006","unstructured":"Lippi G, Caramaschi P, Montagnana M, Salvagno GL, Volpe A, Guidi G (2006) Lipoprotein[a] and the lipid profile in patients with systemic sclerosis. Clin Chim Acta 364:345\u2013348. https:\/\/doi.org\/10.1016\/j.cca.2005.07.015","journal-title":"Clin Chim Acta"},{"key":"5932_CR30","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1002\/art.23540","volume":"59","author":"V Khurma","year":"2008","unstructured":"Khurma V, Meyer C, Park GS, McMahon M, Lin J, Singh RR, Khanna D (2008) A pilot study of subclinical coronary atherosclerosis in systemic sclerosis: coronary artery calcification in cases and controls. Arthritis Rheum 59:591\u2013597. https:\/\/doi.org\/10.1002\/art.23540","journal-title":"Arthritis Rheum"},{"key":"5932_CR31","doi-asserted-by":"publisher","first-page":"R49","DOI":"10.1186\/ar2408","volume":"10","author":"ME Hettema","year":"2008","unstructured":"Hettema ME, Zhang D, de Leeuw K, Stienstra Y, Smit AJ, Kallenberg CG, Bootsma H (2008) Early atherosclerosis in systemic sclerosis and its relation to disease or traditional risk factors. Arthritis Res Ther 10:R49. https:\/\/doi.org\/10.1186\/ar2408","journal-title":"Arthritis Res Ther"},{"key":"5932_CR32","doi-asserted-by":"publisher","first-page":"1409","DOI":"10.1093\/rheumatology\/ken248","volume":"47","author":"ME Hettema","year":"2008","unstructured":"Hettema ME, Zhang D, Stienstra Y, Oomen PN, Smit AJ, Kallenberg CG, Bootsma H (2008) Decreased capillary permeability and capillary density in patients with systemic sclerosis using large-window sodium fluorescein videodensitometry of the ankle. Rheumatology (Oxford) 47:1409\u20131412. https:\/\/doi.org\/10.1093\/rheumatology\/ken248","journal-title":"Rheumatology (Oxford)"},{"key":"5932_CR33","doi-asserted-by":"publisher","first-page":"1517","DOI":"10.1007\/s10067-008-0958-1","volume":"27","author":"A Cypiene","year":"2008","unstructured":"Cypiene A, Laucevicius A, Venalis A, Dadoniene J, Ryliskyte L, Petrulioniene Z, Kovaite M, Gintautas J (2008) The impact of systemic sclerosis on arterial wall stiffness parameters and endothelial function. Clin Rheumatol 27:1517\u20131522. https:\/\/doi.org\/10.1007\/s10067-008-0958-1","journal-title":"Clin Rheumatol"},{"key":"5932_CR34","doi-asserted-by":"publisher","first-page":"243","DOI":"10.3233\/CH-2008-1133","volume":"40","author":"A Vay\u00e1","year":"2008","unstructured":"Vay\u00e1 A, Todol\u00ed J, Calvo J, Romagnoli M, Ricart JM (2008) Haemorheological profile in patients with systemic sclerosis. Clin Hemorheol Microcirc 40:243\u2013248","journal-title":"Clin Hemorheol Microcirc"},{"key":"5932_CR35","doi-asserted-by":"publisher","first-page":"326","DOI":"10.3109\/03009741003605648","volume":"39","author":"N Tsifetaki","year":"2010","unstructured":"Tsifetaki N, Georgiadis AN, Alamanos Y, Fanis S, Argyropoulou MI, Drosos AA (2010) Subclinical atherosclerosis in scleroderma patients. Scand J Rheumatol 39:326\u2013329. https:\/\/doi.org\/10.3109\/03009741003605648","journal-title":"Scand J Rheumatol"},{"key":"5932_CR36","doi-asserted-by":"publisher","first-page":"1387","DOI":"10.1002\/art.30283","volume":"63","author":"MY Mok","year":"2011","unstructured":"Mok MY, Lau CS, Chiu SS, Tso AW, Lo Y, Law LS, Mak KF, Wong WS, Khong PL, Lam KS (2011) Systemic sclerosis is an independent risk factor for increased coronary artery calcium deposition. Arthritis Rheum 63:1387\u20131395. https:\/\/doi.org\/10.1002\/art.30283","journal-title":"Arthritis Rheum"},{"key":"5932_CR37","doi-asserted-by":"publisher","first-page":"704","DOI":"10.1093\/rheumatology\/ket411","volume":"53","author":"E Schiopu","year":"2014","unstructured":"Schiopu E, Au KM, McMahon MA, Kaplan MJ, Divekar A, Singh RR, Furst DE, Clements PJ, Ragvendra N, Zhao W, Maranian P, Khanna D (2014) Prevalence of subclinical atherosclerosis is increased in systemic sclerosis and is associated with serum proteins: a cross-sectional, controlled study of carotid ultrasound. Rheumatology (Oxford) 53:704\u2013713. https:\/\/doi.org\/10.1093\/rheumatology\/ket411","journal-title":"Rheumatology (Oxford)"},{"key":"5932_CR38","doi-asserted-by":"publisher","first-page":"706","DOI":"10.1111\/1756-185x.12332","volume":"19","author":"K Winsz-Szczotka","year":"2016","unstructured":"Winsz-Szczotka K, Ku\u017anik-Trocha K, Komosi\u0144ska-Vassev K, Kucharz E, Kotulska A, Olczyk K (2016) Relationship between adiponectin, leptin, IGF-1 and total lipid peroxides plasma concentrations in patients with systemic sclerosis: possible role in disease development. Int J Rheum Dis 19:706\u2013714. https:\/\/doi.org\/10.1111\/1756-185x.12332","journal-title":"Int J Rheum Dis"},{"key":"5932_CR39","doi-asserted-by":"publisher","first-page":"1535","DOI":"10.1007\/s10067-016-3266-1","volume":"35","author":"S Yolbas","year":"2016","unstructured":"Yolbas S, Kara M, Yilmaz M, Aydin S, Koca SS (2016) Serum adropin level and ENHO gene expression in systemic sclerosis. Clin Rheumatol 35:1535\u20131540. https:\/\/doi.org\/10.1007\/s10067-016-3266-1","journal-title":"Clin Rheumatol"},{"key":"5932_CR40","doi-asserted-by":"publisher","first-page":"14","DOI":"10.5152\/eurjrheum.2014.004","volume":"1","author":"SS Koca","year":"2014","unstructured":"Koca SS, \u00d6zgen M, I\u015f\u0131k B, Da\u011fl\u0131 MN, \u00dcst\u00fcnda\u011f B, I\u015f\u0131k A (2014) Serum salusin-\u03b1 levels in systemic lupus erythematosus and systemic sclerosis. Eur J Rheumatol 1:14\u201317. https:\/\/doi.org\/10.5152\/eurjrheum.2014.004","journal-title":"Eur J Rheumatol"},{"key":"5932_CR41","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1111\/1756-185x.12987","volume":"20","author":"MM Sedky Abdou","year":"2017","unstructured":"Sedky Abdou MM, El Desouky SM, Helmy El Kaffas KM, Ahmed Hassan AM (2017) Premature atherosclerosis in systemic sclerosis patients: its relation to disease parameters and to traditional risk factors. Int J Rheum Dis 20:383\u2013389. https:\/\/doi.org\/10.1111\/1756-185x.12987","journal-title":"Int J Rheum Dis"},{"key":"5932_CR42","doi-asserted-by":"publisher","first-page":"114","DOI":"10.3389\/fmed.2018.00114","volume":"5","author":"J Rodr\u00edguez-Carrio","year":"2018","unstructured":"Rodr\u00edguez-Carrio J, Mozo L, L\u00f3pez P, Nikiphorou E, Su\u00e1rez A (2018) Anti-High-Density lipoprotein antibodies and antioxidant dysfunction in immune-driven diseases. Front Med (Lausanne) 5:114. https:\/\/doi.org\/10.3389\/fmed.2018.00114","journal-title":"Front Med (Lausanne)"},{"key":"5932_CR43","first-page":"18","volume":"125","author":"I Ferraz-Amaro","year":"2020","unstructured":"Ferraz-Amaro I, Delgado-Fr\u00edas E, Hern\u00e1ndez-Hern\u00e1ndez V, S\u00e1nchez-P\u00e9rez H, de Armas-Rillo L, Garc\u00eda-Dopico JA, D\u00edaz-Gonz\u00e1lez F (2020) Proprotein convertase subtilisin\/kexin type 9 in patients with systemic sclerosis. Clin Exp Rheumatol 38 Suppl 125:18\u201324","journal-title":"Clin Exp Rheumatol 38 Suppl"},{"key":"5932_CR44","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1080\/03009742.2020.1837237","volume":"50","author":"HB Kim","year":"2021","unstructured":"Kim HB, Kim A, Kim Y, Kim GT, Ahn E, So MW, Sohn DH, Lee SG (2021) Associations of serum monocyte-to-high-density lipoprotein cholesterol ratio with digital ulcers and skin fibrosis in patients with systemic sclerosis. Scand J Rheumatol 50:231\u2013238. https:\/\/doi.org\/10.1080\/03009742.2020.1837237","journal-title":"Scand J Rheumatol"},{"key":"5932_CR45","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1186\/s13075-021-02443-9","volume":"23","author":"I Ferraz-Amaro","year":"2021","unstructured":"Ferraz-Amaro I, Delgado-Fr\u00edas E, Hern\u00e1ndez-Hern\u00e1ndez V, S\u00e1nchez-P\u00e9rez H, de Armas-Rillo L, Armas-Gonz\u00e1lez E, Machado JD, Diaz-Gonz\u00e1lez F (2021) HDL cholesterol efflux capacity and lipid profile in patients with systemic sclerosis. Arthritis Res Ther 23:62. https:\/\/doi.org\/10.1186\/s13075-021-02443-9","journal-title":"Arthritis Res Ther"},{"key":"5932_CR46","doi-asserted-by":"publisher","DOI":"10.3390\/nu13020705","author":"G Isola","year":"2021","unstructured":"Isola G, Palazzo G, Polizzi A, Murabito P, Giuffrida C, Lo Gullo A (2021) Association of systemic sclerosis and periodontitis with vitamin D levels. Nutrients. https:\/\/doi.org\/10.3390\/nu13020705","journal-title":"Nutrients"},{"key":"5932_CR47","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1007\/s10067-021-05887-1","volume":"41","author":"N Afifi","year":"2022","unstructured":"Afifi N, Khalifa MMM, Al Anany A, Hassan H (2022) Cardiac calcium score in systemic sclerosis. Clin Rheumatol 41:105\u2013114. https:\/\/doi.org\/10.1007\/s10067-021-05887-1","journal-title":"Clin Rheumatol"},{"key":"5932_CR48","doi-asserted-by":"publisher","first-page":"rkac048","DOI":"10.1093\/rap\/rkac048","volume":"6","author":"T Nguyen Thi Phuong","year":"2022","unstructured":"Nguyen Thi Phuong T, Dao Thi T, Lundberg IE, Nguyen Huy B (2022) Atherosclerosis in Vietnamese patients with systemic sclerosis and its relationship to disease and traditional risk factors. Rheumatol Adv Pract 6:rkac048. https:\/\/doi.org\/10.1093\/rap\/rkac048","journal-title":"Rheumatol Adv Pract"},{"key":"5932_CR49","doi-asserted-by":"publisher","first-page":"249","DOI":"10.46497\/ArchRheumatol.2023.9638","volume":"38","author":"J Artin","year":"2023","unstructured":"Artin J, Elsabagh YA, Rashed L, Hussein MA (2023) Proprotein convertase subtilisin\/kexin 9 (PCSK9) in patients with diffuse systemic sclerosis: a marker of disease activity and severe disease manifestations with potential therapeutic implementations. Arch Rheumatol 38:249\u2013256. https:\/\/doi.org\/10.46497\/ArchRheumatol.2023.9638","journal-title":"Arch Rheumatol"},{"key":"5932_CR50","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1007\/s00296-023-05421-3","volume":"44","author":"G Mart\u00ednez-D\u00edaz","year":"2024","unstructured":"Mart\u00ednez-D\u00edaz G, Cruz-Dom\u00ednguez MP, L\u00f3pez Zamora B, Ramirez-Facio J, Medina G, Mungu\u00eda-Cruz RX, Saavedra-Salinas MA, Arrucha-Cozaya M, Vera-Lastra OL, Peralta-Amaro AL, Florez-Durante \u00d3I, Gil-Galindo KA (2024) Influence of visceral adiposity on cardiovascular risk in patients with systemic sclerosis. Rheumatol Int 44:621\u2013630. https:\/\/doi.org\/10.1007\/s00296-023-05421-3","journal-title":"Rheumatol Int"},{"key":"5932_CR51","doi-asserted-by":"publisher","first-page":"1446268","DOI":"10.3389\/fmed.2024.1446268","volume":"11","author":"U Heilmeier","year":"2024","unstructured":"Heilmeier U, Feldmann D, Leynes A, Seng M, Jandova I, Keute M, Kollert F, Voll RE, Finzel S (2024) Chronic low-grade inflammation in patients with systemic sclerosis is associated with increased risk for arteriosclerotic cardiovascular disease. Front Med (Lausanne) 11:1446268. https:\/\/doi.org\/10.3389\/fmed.2024.1446268","journal-title":"Front Med (Lausanne)"},{"key":"5932_CR52","doi-asserted-by":"publisher","first-page":"1095","DOI":"10.2147\/clep.S427881","volume":"15","author":"OC Kwon","year":"2023","unstructured":"Kwon OC, Han K, Park MC (2023) Association between lipid profile and risk of incident systemic sclerosis: a nationwide Population-Based study. Clin Epidemiol 15:1095\u20131107. https:\/\/doi.org\/10.2147\/clep.S427881","journal-title":"Clin Epidemiol"},{"key":"5932_CR53","doi-asserted-by":"publisher","first-page":"1530909","DOI":"10.3389\/fimmu.2025.1530909","volume":"16","author":"R Guo","year":"2025","unstructured":"Guo R, Gao J, Yang Y, Xu K (2025) Aberrant lipid profiles and lymphocyte counts in systemic sclerosis population, reassessing predictive value for concurrent cardiovascular diseases. Front Immunol 16:1530909. https:\/\/doi.org\/10.3389\/fimmu.2025.1530909","journal-title":"Front Immunol"},{"key":"5932_CR54","doi-asserted-by":"publisher","first-page":"107825","DOI":"10.1016\/j.rmed.2024.107825","volume":"234","author":"ST Jendrek","year":"2024","unstructured":"Jendrek ST, Schmelter F, Schinke S, Hackel A, Gra\u00dfhoff H, Lamprecht P, Humrich JY, Sina C, M\u00fcller A, G\u00fcnther U, Riemekasten G (2024) Metabolomic signature identifies HDL and apolipoproteins as potential biomarker for systemic sclerosis with interstitial lung disease. Respir Med 234:107825. https:\/\/doi.org\/10.1016\/j.rmed.2024.107825","journal-title":"Respir Med"},{"key":"5932_CR55","doi-asserted-by":"publisher","first-page":"1915","DOI":"10.2147\/jir.S282691","volume":"14","author":"GE Fragoulis","year":"2021","unstructured":"Fragoulis GE, Soulaidopoulos S, Sfikakis PP, Dimitroulas T, G DK (2021) Effect of biologics on cardiovascular inflammation: mechanistic insights and risk reduction. J Inflamm Res 14:1915\u20131931. https:\/\/doi.org\/10.2147\/jir.S282691","journal-title":"J Inflamm Res"},{"key":"5932_CR56","doi-asserted-by":"publisher","first-page":"736","DOI":"10.1191\/0961203305lu2211oa","volume":"14","author":"E Matsuura","year":"2005","unstructured":"Matsuura E, Kobayashi K, Inoue K, Lopez LR, Shoenfeld Y (2005) Oxidized LDL\/beta2-glycoprotein I complexes: new aspects in atherosclerosis. Lupus 14:736\u2013741. https:\/\/doi.org\/10.1191\/0961203305lu2211oa","journal-title":"Lupus"},{"key":"5932_CR57","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1016\/0306-9877(87)90123-x","volume":"14","author":"DF Horrobin","year":"1984","unstructured":"Horrobin DF (1984) Essential fatty acid metabolism in diseases of connective tissue with special reference to scleroderma and to sjogren\u2019s syndrome. Med Hypotheses 14:233\u2013247. https:\/\/doi.org\/10.1016\/0306-9877(87)90123-x","journal-title":"Med Hypotheses"},{"key":"5932_CR58","doi-asserted-by":"publisher","DOI":"10.3390\/cells10051104","author":"Y Shima","year":"2021","unstructured":"Shima Y (2021) Cytokines involved in the pathogenesis of SSc and problems in the development of anti-cytokine therapy. Cells. https:\/\/doi.org\/10.3390\/cells10051104","journal-title":"Cells"},{"key":"5932_CR59","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1016\/j.atherosclerosis.2006.05.024","volume":"192","author":"G Zuliani","year":"2007","unstructured":"Zuliani G, Volpato S, Bl\u00e8 A, Bandinelli S, Corsi AM, Lauretani F, Paolisso G, Fellin R, Ferrucci L (2007) High interleukin-6 plasma levels are associated with low HDL-C levels in community-dwelling older adults: the InChianti study. Atherosclerosis 192:384\u2013390. https:\/\/doi.org\/10.1016\/j.atherosclerosis.2006.05.024","journal-title":"Atherosclerosis"},{"issue":"Suppl 3","key":"5932_CR60","doi-asserted-by":"publisher","first-page":"S462","DOI":"10.1086\/315611","volume":"181\u00a0","author":"W Khovidhunkit","year":"2000","unstructured":"Khovidhunkit W, Memon RA, Feingold KR, Grunfeld C (2000) Infection and inflammation-induced proatherogenic changes of lipoproteins. J Infect Dis 181\u00a0(Suppl 3):S462-472. https:\/\/doi.org\/10.1086\/315611","journal-title":"J Infect Dis"},{"key":"5932_CR61","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.athplu.2023.09.003","volume":"54","author":"A Makris","year":"2023","unstructured":"Makris A, Pagkali A, Nikolousis E, Filippatos TD, Agouridis AP (2023) High-density lipoprotein cholesterol and multiple myeloma: a systematic review and meta-analysis. Atheroscler Plus 54:7\u201313. https:\/\/doi.org\/10.1016\/j.athplu.2023.09.003","journal-title":"Atheroscler Plus"},{"key":"5932_CR62","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1016\/j.jacl.2012.06.009","volume":"6","author":"AP Agouridis","year":"2012","unstructured":"Agouridis AP, Liberopoulos EN, Kostapanos MS, Elisaf MS (2012) New-onset extremely low levels of high-density lipoprotein cholesterol. J Clin Lipidol 6:593\u2013595. https:\/\/doi.org\/10.1016\/j.jacl.2012.06.009","journal-title":"J Clin Lipidol"},{"key":"5932_CR63","doi-asserted-by":"publisher","first-page":"734","DOI":"10.1016\/j.atherosclerosis.2011.09.015","volume":"219","author":"AD Protogerou","year":"2011","unstructured":"Protogerou AD, Zampeli E, Fragiadaki K, Stamatelopoulos K, Papamichael C, Sfikakis PP (2011) A pilot study of endothelial dysfunction and aortic stiffness after interleukin-6 receptor Inhibition in rheumatoid arthritis. Atherosclerosis 219:734\u2013736. https:\/\/doi.org\/10.1016\/j.atherosclerosis.2011.09.015","journal-title":"Atherosclerosis"},{"key":"5932_CR64","unstructured":"Feingold KR, Grunfeld C et al (2000) The Effect of Inflammation and Infection on Lipids and Lipoproteins. In: Endotext (eds. Feingold, K.R., (MDText.com, Inc. Copyright \u00a9 2000\u20132025, MDText.com, Inc., South Dartmouth (MA)"},{"key":"5932_CR65","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.athplu.2021.08.007","volume":"44","author":"AP Agouridis","year":"2021","unstructured":"Agouridis AP, Pagkali A, Zintzaras E, Rizos EC, Ntzani EE (2021) High-density lipoprotein cholesterol: a marker of COVID-19 infection severity? Atheroscler Plus 44:1\u20139. https:\/\/doi.org\/10.1016\/j.athplu.2021.08.007","journal-title":"Atheroscler Plus"},{"key":"5932_CR66","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1007\/s15010-017-1022-3","volume":"45","author":"S Filippas-Ntekouan","year":"2017","unstructured":"Filippas-Ntekouan S, Liberopoulos E, Elisaf M (2017) Lipid testing in infectious diseases: possible role in diagnosis and prognosis. Infection 45:575\u2013588. https:\/\/doi.org\/10.1007\/s15010-017-1022-3","journal-title":"Infection"},{"key":"5932_CR67","doi-asserted-by":"publisher","first-page":"G980","DOI":"10.1152\/ajpgi.00080.2010","volume":"299","author":"JD Sparks","year":"2010","unstructured":"Sparks JD, Cianci J, Jokinen J, Chen LS, Sparks CE (2010) Interleukin-6 mediates hepatic hypersecretion of Apolipoprotein B. Am J Physiol Gastrointest Liver Physiol 299:G980\u2013989. https:\/\/doi.org\/10.1152\/ajpgi.00080.2010","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"5932_CR68","first-page":"629","volume":"32","author":"M Kodera","year":"2005","unstructured":"Kodera M, Hayakawa I, Komura K, Yanaba K, Hasegawa M, Takehara K, Sato S (2005) Anti-lipoprotein lipase antibody in systemic sclerosis: association with elevated serum triglyceride concentrations. J Rheumatol 32:629\u2013636","journal-title":"J Rheumatol"},{"key":"5932_CR69","doi-asserted-by":"publisher","first-page":"103695","DOI":"10.1016\/j.autrev.2024.103695","volume":"24","author":"JF de Carvalho","year":"2025","unstructured":"de Carvalho JF, Skare TL (2025) Anti-lipoprotein lipase antibodies: A review. Autoimmun Rev 24:103695. https:\/\/doi.org\/10.1016\/j.autrev.2024.103695","journal-title":"Autoimmun Rev"},{"key":"5932_CR70","doi-asserted-by":"publisher","first-page":"1878","DOI":"10.1016\/s0140-6736(23)00457-9","volume":"401","author":"N Conrad","year":"2023","unstructured":"Conrad N, Misra S, Verbakel JY, Verbeke G, Molenberghs G, Taylor PN, Mason J, Sattar N, McMurray JJV, McInnes IB, Khunti K, Cambridge G (2023) Incidence, prevalence, and co-occurrence of autoimmune disorders over time and by age, sex, and socioeconomic status: a population-based cohort study of 22 million individuals in the UK. Lancet 401:1878\u20131890. https:\/\/doi.org\/10.1016\/s0140-6736(23)00457-9","journal-title":"Lancet"},{"key":"5932_CR71","doi-asserted-by":"publisher","first-page":"76","DOI":"10.2174\/1874192401105010076","volume":"5","author":"CV Rizos","year":"2011","unstructured":"Rizos CV, Elisaf MS, Liberopoulos EN (2011) Effects of thyroid dysfunction on lipid profile. Open Cardiovasc Med J 5:76\u201384. https:\/\/doi.org\/10.2174\/1874192401105010076","journal-title":"Open Cardiovasc Med J"},{"key":"5932_CR72","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/s0009-8981(97)00212-x","volume":"271","author":"G Lippi","year":"1998","unstructured":"Lippi G, Braga V, Adami S, Guidi G (1998) Modification of serum Apolipoprotein A-I, Apolipoprotein B and lipoprotein(a) levels after bisphosphonates-induced acute phase response. Clin Chim Acta 271:79\u201387. https:\/\/doi.org\/10.1016\/s0009-8981(97)00212-x","journal-title":"Clin Chim Acta"},{"key":"5932_CR73","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.athplu.2023.09.001","volume":"54","author":"A Makris","year":"2023","unstructured":"Makris A, Barkas F, Sfikakis PP, Liberopoulos E, Filippatos TD, Ray KK, Agouridis AP (2023) Lipoprotein(a), Interleukin-6 inhibitors, and atherosclerotic cardiovascular disease: is there an association? Atheroscler Plus 54:1\u20136. https:\/\/doi.org\/10.1016\/j.athplu.2023.09.001","journal-title":"Atheroscler Plus"},{"key":"5932_CR74","doi-asserted-by":"publisher","first-page":"923289","DOI":"10.1155\/2012\/923289","volume":"2012","author":"K Riches","year":"2012","unstructured":"Riches K, Porter KE (2012) Lipoprotein(a): cellular effects and molecular mechanisms. Cholesterol 2012:923289. https:\/\/doi.org\/10.1155\/2012\/923289","journal-title":"Cholesterol"},{"key":"5932_CR75","doi-asserted-by":"publisher","first-page":"e24719","DOI":"10.1371\/journal.pone.0024719","volume":"6","author":"HK Berthold","year":"2011","unstructured":"Berthold HK, Laudes M, Krone W, Gouni-Berthold I (2011) Association between the interleukin-6 promoter polymorphism\u2013\u2009174G\/C and serum lipoprotein(a) concentrations in humans. PLoS One 6:e24719. https:\/\/doi.org\/10.1371\/journal.pone.0024719","journal-title":"PLoS One"}],"container-title":["Rheumatology International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00296-025-05932-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00296-025-05932-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00296-025-05932-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,8]],"date-time":"2025-09-08T18:46:16Z","timestamp":1757357176000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00296-025-05932-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,5]]},"references-count":75,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2025,8]]}},"alternative-id":["5932"],"URL":"https:\/\/doi.org\/10.1007\/s00296-025-05932-1","relation":{},"ISSN":["1437-160X"],"issn-type":[{"value":"1437-160X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,5]]},"assertion":[{"value":"16 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 July 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 August 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Editing was not supported by any agency in the present manuscript.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Editing"}},{"value":"No AI software was used in any part of the present manuscript.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"AI usage"}},{"value":"The authors declare no Competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"182"}}